The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Breaking primary checkpoint inhibitor resistance: Interim analysis of a multicenter phase II study by intermittent application of an alkylating agent among patients with metastatic melanoma.
 
Lucie Heinzerling
Consulting or Advisory Role - BMS GmbH & Co. KG; CureVac; MSD Oncology; Novartis; Pierre Fabre; Sanofi; Sun Pharma; Therakos
Research Funding - Therakos (Inst)
Patents, Royalties, Other Intellectual Property - Patent on IL12 encodg plasmid; patent on lymphangiogenesis; patent on soluble markers
 
Sebastian Haferkamp
Honoraria - Amgen; Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - AMGEN; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
 
Bastian Schilling
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pfizer/EMD Serono; Pierre Fabre; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sanofi Aventis GmbH
Research Funding - Novartis (Inst); Pierre Fabre (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
 
Carola Berking
Honoraria - Almirall Hermal GmbH; Bristol-Myers Squibb; LEO Pharma; MSD; Novartis; Sanofi/Aventis
Consulting or Advisory Role - Almirall Hermal GmbH; Bristol-Myers Squibb; Immunocore; InflaRx; MSD; Novartis; Pierre Fabre; Sanofi/Aventis; Sanofi/Regeneron
Research Funding - Almirall Hermal GmbH (Inst); Bristol-Myers Squibb (Inst); immatics (Inst); InflaRx (Inst); IO Biotech (Inst); Kartos Therapeutics (Inst); Pfizer (Inst)
 
Ed Geissler
Consulting or Advisory Role - CSL Behring; Quell
Research Funding - Chiesi (Inst)
 
Florian Zeman
No Relationships to Disclose